NeuroPace: Only For Those With Strong Nerves [Seeking Alpha]
Neuropace, Inc. (NPCE)
Company Research
Source: Seeking Alpha
Follow Summary NeuroPace, Inc. aims to improve the lives of epilepsy patients with RNS technology, addressing drug-resistant epilepsy. The company has seen revenue growth, but continues to post losses nonetheless. NeuroPace stock is displaying substantial volatility and looks interesting on a highly speculative basis, anticipating wider approval of RNS. koto_feja In February, I was last picking up the pace in the case of NeuroPace, Inc. ( NASDAQ: NPCE after shares doubled since September 2023, aided by strong operating momentum. After shares tripled in a relatively short period of time, it was an Recommended For You About NPCE Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
NPCE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NPCE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NPCE alerts
High impacting Neuropace, Inc. news events
Weekly update
A roundup of the hottest topics
NPCE
News
- NeuroPace Strengthens Management Team with Two Key AppointmentsGlobeNewswire
- NeuroPace Announces Participation at Two Upcoming Healthcare Investor ConferencesGlobeNewswire
- NeuroPace to Participate in Upcoming Healthcare Conferences in SeptemberGlobeNewswire
- NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up [Yahoo! Finance]Yahoo! Finance
- Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57 [Yahoo! Finance]Yahoo! Finance
NPCE
Earnings
- 8/13/24 - Beat
NPCE
Sec Filings
- 8/13/24 - Form 10-Q
- 8/13/24 - Form 8-K
- NPCE's page on the SEC website